Hyperimmune rabbit and mouse sera raised to human herpesvirus 7 (HHV-7)-infected cells and an immune human serum identified 20 [35S]methionine-[ZSS]cysteinelabelled proteins specific for HHV-7-infected cord blood mononuclear cells, ranging in apparent Mr from 136K to 30K. The major proteins had apparent M r values of 121K,
Introduction
Two human herpesviruses, human herpesvirus 6 (HHV-6) and 7 (HHV-7) have been discovered in recent years (Salahuddin et al., 1986; Downing et al., 1987; Lopez et al., 1988; Frenkel et al., 1990) . Both infect T lymphocytes, and can be reactivated in vitro from peripheral blood mononuclear cells (PBMCs), probably as a result of reactivation from a latent state (Kondo et al., 1991; Pellett et al., 1992; Frenkel et aL, 1992) . The HHV-6 strains have been subdivided into two clusters, designated as variants A and B, differing in the restriction endonuclease cleavage pattern of the viral DNAs, growth in continuous cell lines, reactivity to a few monoclonal antibodies (MAbs) and extent of DNA homology (Ablashi et al., 1993) . HHV-6B includes isolates derived from children with exanthem subitum (Yamanishi et al., 1988; Ablashi et al., 1993) .
Very little is known about the recently recognized HHV-7. It was first isolated from CD4 + T lymphocytes of a healthy individual, following mitogenic activation of the cells (Frenkel et al., 1990) . Subsequent isolates were derived from PBMCs of healthy individuals , of a patient with chronic fatigue syndrome (Berneman et al., 1992b) , and from the saliva of normal adults (Black et al., 1993; . Both HHV-6 and -7 are highly prevalent among humans (Clark et al., 1993; Pellett et al., 1992; Wyatt et al., 1991) . Both HHV-6 and -7 are shed in the saliva (Black et al., 1993; Cone et aL, 1993; Frenke| & Wyatt, 1992) . Hybridization analysis of viral DNA indicates that HHV-7 is distinct from any other herpesvirus, with the exception of HHV-6, with which it shares limited sequence homology (Berneman et al., 1992a; Frenkel et al., 1990) .
So far, virtually nothing is known of the HHV-7-encoded proteins. The objectives of this study were to obtain a preliminary identification of proteins specific for HHV-7-infected human T cells, to develop reagents to them, and to investigate whether they share common epitopes with proteins from other herpesviruses, particularly HHV-6. Three series of approaches were undertaken. First, we developed rabbit and mouse hyperimmune sera against HHV-7-infected cells and compared the proteins immunoprecipitated by hyperimmune animal sera with those immunoprecipitated by an immune human serum. Second, we developed four MAbs to three proteins occurring in HHV-7-infected cells. Finally, we analysed these antibodies for crossreactivity towards HHV-6A and -6B, and conversely the cross-reactivity of a number of HHV-6-specific MAbs towards HHV-7.
Methods

Cells and viruses.
Cord blood mononuclear cells (CBMCs) were grown as described (Fo~-Tomasi et al., 1991) . HHV-7 strain RK, obtained from Dr N. Frenkel, was grown in CBMCs with prior stimulation for 2 days with 5 gg/ml phytohaemagglutinin (PHA-P), and 2 further days with PHA-P and recombinant interleukin 2 (5 U/ml), as previously detailed for HHV-6 (Foh-q'omasi et al., 1991) . Except when otherwise stated, for virus propagation, infected CBMCs were mixed with uninfected CBNCs in an approximate ratio of 1 : 5. In the infected cultures employed for antigen preparation and for labelling experiments, the percent of fluorescence-positive cells ranged from 30 to 60%. Infection was monitored by indirect immunofluorescence assay (IFA) with a human immune serum, for which the titre in indirect immunofluorescence was 1:640, or with the MAbs derived in this study. HHV-6A(Ull02) and -6B(Z29) were grown in CBMCs, as detailed (Fo~t-Tomasi et al., 1991) . X63-Ag8. 653 myeloma cells and hybridoma cells were grown in Iscove medium supplemented with 10 % inactivated fetal calf serum.
Production of polyvalent rabbit and mouse sera to HHV-7-infected
CBMCs. A female New Zealand white rabbit was immunized by subcutaneous injection with 500 gg of a lysate of HHV-7-infected CBMCs, made in 0.5 % Triton X100 and clarified by centrifugation at 100000g for 1 h. The lysate was emulsified with complete Freund adjuvant for the first injection, and with incomplete Freund's adjuvant in the three subsequent injections administered at 2 to 4 week intervals. Six to 8-week-old inbred BALB/c mice were immunized by footpad injection with 200 gg of a lysate of HHV-7-infected CBMCs, made as above. The mice were reinjected twice at 2-week intervals by intraperitoneal injection of the same lysate, emulsified in incomplete Freund's adjuvant, and finally received a fourth intraperitoneal injection of the lysate without adjuvant.
Production of MAbs.
Mouse spleen cells were fused with X63-Ag8. 653 myeloma cells and the hybridoma cells were selected according to standard procedure, as previously detailed (Foh-Tomasi et al., 1991) . The culture fluids of the hybridomas were assayed for the presence of antibodies reactive with HHV-7-infected CBMCs by means of an ELISA.
ELISA and IFA. For ELISA 96-well plates were coated at 4 °C overnight with lysates of HHV-7-infected or mock-infected CBMCs (0.5 to 1 gg of protein/well), diluted in sodium bicarbonate buffer pH 9.4, as previously detailed for HHV-6A(U1102) (Foh-Tomasi et al., 1991) . Hybridoma culture fluids that gave an optical density twofold higher against HHV-7-infected cell lysates relative to the mock-infected cell lysates were considered to be positive. For indirect IFA the cells were fixed with cold acetone and stained with the hybridoma culture fluid, ascites fluids, or mouse, rabbit or human sera, by means of fluorescein isothiocyanate-conjugated anti-immunoglobulins. Immunoprecipitation and Western blot. For immunoprecipitations, cells were lysed in 1% NP40, 1% sodium deoxycholate in PBS containing 10 -5 M each of tolylsulphonyl phenylalanyl chloromethyl ketone and ~-tosyl-L-lysine chloromethyl ketone, and centrifuged at 100000g for 1 h. The lysate was incubated with MAbs or rabbit, mouse, human sera and the immunoprecipitates were collected with Protein A-Sepharose beads, as previously detailed (Fo~t-Tomasi et al., 1991) . For Western blot, lysates of HHV-7-infected and mock-infected CBMCs were subjected to denaturing PAGE and the separated proteins were transferred to nitrocellulose sheet. Antibody binding was visualized by reaction with rabbit anti-mouse immunoglobulins conjugated with alkaline phosphatase (Immune-blot assay kit from Bio-Rad).
Labelling of cells. HHV-7-infected
PAGE. Samples were subjected to denaturing electrophoresis in 8.5 % polyacrylamide gels cross-linked with N-N'-diallyltartardiamide. The gels were fixed, soaked with Amplify (Amersham), dried and exposed to Kodak X-Omat films for fluorography.
Results
Polyvalent rabbit and mouse and immune human sera identify major immunogenic proteins specific for HHV-7-infected cells
A polyvalent rabbit serum to HHV-7-infected CBMCs was raised by subcutaneous injection of a rabbit with a lysate of HHV-7-infected CBMCs. Polyvalent mouse sera were raised by footpad injection of 6-to 8-week-old female BALB/c mice with the same lysate. The rabbit and mouse sera showed a strong immunofluorescence reactivity to acetone-fixed HHV-7-infected CBMCs, at a dilution range of 1:4096 to 1:8192, and a weaker reactivity towards the uninfected CBMCs (data not shown). To identify the proteins specific for HHV-7-infected cells a radioimmunoprecipitation reaction was performed with the rabbit and mouse hyperimmune sera, and with a human serum positive by immunofluorescence towards HHV-7-infected CBMCs at a 1:640 dilution. The sera were allowed to react with lysates of HHV-7-infected and uninfected [sSS]methionine-[a~S]cysteinelabelled CBMCs. The immunocomplexes were harvested with Protein A-Sepharose beads and separated by denaturing electrophoresis. . 2) ; the 87K M r polypeptide is recognized by MAbs 3B1 and 5El (see Fig. 4 ). As far as the 46K, 42K and 36K Mr polypeptides are concerned, it remains to be established using molecular genetics whether they represent HHV-7-infected cell-specific proteins or cellular proteins for which synthesis is induced by HHV-7 infection. (iii) A remarkable feature was the strong similarity in the electrophoretic profile of the proteins immunoprecipitated by human, mice or rabbit sera, implying that the proteins immunogenic to humans are immunogenic to the laboratory animals also. It can be predicted that the coding capacity of the HHV-7 genome exceeds by far the proteins identified here. Several explanations may account for this underestimation. Among them are: low immunogenicity of some of the proteins; technical reasons, e.g. overlapping of different proteins with the same electrophoretic mobility; and the possibility that the detergents used to derive the antigens employed in 
Human immune serum identifies glycosylated proteins
To identify the glycoproteins specific for HHV-7-infected cells, an immunoprecipitation reaction was carried out with the human immune serum on lysates of [3H]glucosamine-labelled HHV-7-infected CBMCs. Fig. 2 shows that seven [3H]glucosamine-labelled polypeptides specific for HHV-7-infected cells were immunoprecipitated by the human serum. Their apparent M r values are 100K, 89K, 82K, 67K, 63K, 53K and 41K. The hyperimmune mouse serum gave an identical immunoprecipitation profile (not shown). These results suggest, although do not unequivocally prove, that HHV-7 may encode a number of glycoproteins, as do other herpesviruses. Given the differences in the electrophoretic profile of the glycoproteins immunoprecipitated from infected versus uninfected cells, the results also suggest a rapid turnover or, alternatively, a virus-induced shut-off of host glycoprotein synthesis.
MAbs specific to HHV-7-infected cell proteins
MAbs were derived in order to generate monospecific reagents able to identify individual HHV-7-specific immunogenic proteins. The spleen cells from mouse no.
1 of Fig. 1 were fused with X63-Ag8. 653 myeloma cells, as detailed previously (Fo~-Tomasi et al., I991). Culture fluids from hybridomas were first scored for their reactivity to lysates of HHV-7-infected and uninfected CBMCs in an ELISA test, they were then examined by IFA, and finally by radioimmunoprecipitation with lysates of uninfected and infected cells. The four hybridomas positive in all three tests were cloned twice. Fig. 3 shows the intracellular distribution of the proteins reacting with MAbs 3H12 and 5El as detected by immunofluorescence. In either case the staining localized to the cytoplasm. The staining with MAb 5El localized to the cell periphery, often in a ring-like fashion, and to a prominent mass, which occupies most of the cytoplasm. The staining with MAb 3B1 could not be differentiated from that of MAb 5El (not shown). The staining with MAb 3H12 was clearly differentiable and localized to a few dots in each cell. Fig. 4(a) shows the electrophoretic profile of the proteins immunoprecipitated by the MAbs, from lysates of [35S]methionine-[35S]cysteine-labelled uninfected and HHV-7-infected CBMCs. The four MAbs precipitated only minor amounts of labelled polypeptides from lysates of uninfected cells (Fig. 4, lanes 5, 7, 9 and 11) . From the infected cell lysates a number of labelled polypeptides were immunoprecipitated in minor amounts with all the antibodies tested, as well as from the mouse preimmune serum, and were considered to be unspecifically bound to the Protein A-Sepharose beads. The polypeptides immunoprecipitated specifically were as follows. A single polypeptide of 51K M r was immunoprecipitated by MAb 2C1; the reacting protein was thus designated as p51. A single polypeptide of 121K M r was precipitated by MAb 3H12; the reacting protein was designated as p121. The electrophoretic profile of the proteins immunoprecipitated by MAbs 3B 1 and 5E 1 were virtually undistinguishable from each other, and consisted of at least five polypeptides: two were prominent broadly migrating polypeptides of 87K and 85K Mr, and two polypeptides were 70K and 61K Mr. In addition, a more faintly labelled 57K M r polypeptide was detectable in the immunoprecipitation with MAb 5El, but was virtually absent from the immunoprecipitation using MAb 3B1. As the most prominent band corresponded to 85K M r, the proteins reacting with MAbs 3B1 and 5El were designated as the p85 complex.
To determine whether any of the four MAbs displayed reactivity to denatured proteins, lysates of HHV-7-infected cells were subjected to denaturing PAGE. The separated proteins were transferred to a nitrocellulose sheet, and reacted with the four MAbs. Two of the four MAbs, 3B1 and 5El were able to react with denatured proteins. The electrophoretic profile of the immunoblots was similar to that observed in the immunoprecipitation (Fig. 4b) . We conclude that the two MAbs are directed to conformation-independent epitopes, and that the multiple bands are not due to coprecipitation of antigenically unrelated proteins.
The near identity in the electrophoretic profile of the proteins reacting by immunoprecipitation and immunoblot with MAbs 3B1 and 5El suggested that the two MAbs react with the same cluster of proteins. To ascertain whether this is indeed the case, we took advantage of the ability of the MAbs to react with denatured proteins. Equal portions of a radiolabelled lysate of HHV-7-infected CBMCs were allowed to react with MAb 3B1, MAb 5El, the mouse preimmune and hyperimmune sera. The immunocomplexes were harvested with Protein A-Sepharose beads, subjected to denaturing PAGE, transferred to nitrocellulose sheet, allowed to react with MAb 5El, and finally with alkaline phosphatase-coupled anti-mouse IgGs. 
Reactivity of HHV-7-specific MAbs and hyperimmune sera with HHV-6A and -6B and with other herpesviruses, and of HHV-6-specific MAbs with HHV-7-infected cells
To ascertain whether H H V -7 shares c o m m o n epitopes with other herpesviruses, three series of experiments were performed. In the first, the H H V -7 h y p e r i m m u n e mouse 1 serum was assayed for the ability to i m m u n o p r e c i p i t a t e proteins from lysates of HHV-6B ( Liu et al., 1993) . These data provide evidence for the presence of common epitopes between HHV-7 and -6. They show also that the mouse HHV-7 hyperimmune serum contained negligible amounts of antibodies able to immunoprecipitate HHV-6B gB and gH. This suggests that, at least with our immunization protocol, the major HHV-7 immunogenic proteins were neither gB nor gH homologues.
In the second series of experiments, the MAbs directed to HHV-7-infected cell proteins (2C1, 3H12, 3B1 and 5El) were assayed by indirect immunofluorescence towards CBMCs infected with HHV-6A(Ull02) and -6B(Z29), prototypes of HHV-6 variant A and B strains. The results indicate a weak reactivity of MAbs 5El and 3B1 to HHV-6B(Z29)-and -6A(Ull02)-infected lymphocytes, at a 1:10 dilution (Table 1) . When other herpesviruses were tested, no significant reactivity was noticed with any MAb to Vero cells infected with herpes simplex virus type 1, and B95-8 lymphoblastoid cells chronically infected with Epstein-Barr virus (not shown). A weak reactivity was detected towards human fibroblasts infected with human cytomegalovirus (HCMV) Towne strain, with MAb 3B 1 and to an even lower extent with MAb 5El, all at a 1 : 10 dilution (not shown).
In the third series of experiments, we determined whether any of the MAbs derived in our laboratory to HHV-6A or -6B react with HHV-7-infected CBMCs by immunofluorescence. Table 1 summarizes the HHV-6 proteins recognized by these MAbs, along with the results. Of the antibodies to HHV-6, only MAb 1D3, directed to HHV-6 gH (Liu et al., 1993) , reacted occasionally with HHV-7-infected CBMCs. This observation confirms and extends previous findings that three out of eight MAbs to HHV-6 gave a weak variable cross-reactivity with HHV-7-infected cells (Berneman et al., 1992b; Black et al., 1993; Wyatt et al., 1991) . We do not know the source of the variability. The crossreactivity of a MAb directed to HHV-6 gH with HHV-7 is not surprising in view of the notion that gH is one of two glycoproteins present in almost all the herpesviruses studied to date (Gompels & Minson, 1986 )and its sequence is conserved (Gompels et al., 1988; Liu et al., 1993) .
Discussion
The identification and characterization of HHV-7 proteins is an essential step to our understanding of the biology of the virus, its strategy of replication, its relationship with the human host, its role as a causative agent of disease, its evolution within the Herpesviridae family, and its extent of differentiation from other herpesviruses, particularly other human lymphotropic herpesviruses, like HHV-6. By means of rabbit and mouse polyvalent sera, and a human immune serum, we have identified a minimum of 20 proteins, ranging in apparent M r from 121K to 31K, and seven glycosylated peptides that are expressed in infected cells and are either absent or present in small amounts in the uninfected cells. It is probable that most of them represent HHV-7-encoded proteins, but may also include cellular proteins for which synthesis is induced following HHV-7 infection. Evidence that they are encoded by HHV-7 will require mapping of the coding genes in the viral genome. Electrophoretic profiles of the proteins immunoprecipitated by the hyperimmune rabbit and mouse sera and by the immune human serum were very similar. This may reflect the fact that the antigen employed both as immunogen for rabbit and mice, and in the immunoprecipitation reactions, contained only a subset of the proteins present in the infected cells. In addition, these proteins may represent major HHV-7 immunogenic proteins. Our unpublished observations that a number of human sera react with highest frequency by immunoblot with a 85K polypeptide, and to a lower frequency, with a 121K polypeptide, in conjunction with the report that a human serum reacted by immunoblot with a 91K polypeptide (Wyatt et al., 1991) argue that the p85 complex and p121 are HHV-7 immunodominant proteins for both humans and experimental animals. Neither the p85 complex nor p 121 could be metabolically labelled with [3H]glucosamine. Therefore, unless HHV-7 gB and gH homologues are unglycosylated, the major immunogenic determinants for HHV-7 are likely to be neither gB nor gH homologues.
Four MAbs directed to HHV-7-infected cell-specific proteins were derived in this study. MAbs 3H12 and 2C1 react with p121 and p51, respectively. MAbs 3B1 and 5El are both directed against a protein complex which we have designated as the p85 complex. The near identity in the electrophoretic profiles resulting from the complex of peptides reacting with the MAbs 3B1 and 5El, and the finding that the complex of proteins immunoprecipitated by MAb 3BI are available for reaction with MAb 5El in a sequential immunoprecipitation-immunoblot experiment, increase the likelihood that the p85 complex represents a family of antigenically related polypeptides. The latter are not uncommon among herpesviruses, for example the gB family of HCMV (Pereira, 1985; Spaete et al., 1988) . None of the MAbs neutralized virion infectivity, suggesting that p 121, p51 and the p85 complex are either not part of the virion or are not accessible to the antibodies, and thus are most likely not located in the virion envelope; alternatively they might not be involved in virus entry into cells.
Current data support the conclusion that HHV-7 shares common epitopes with HHV-6. Specifically, the HHV-7-hyperimmune mouse serum immunoprecipitated several proteins from HHV-6-infected CBMCs; two MAbs specific for HHV-7-infected cell proteins crossreacted with HHV-6; in addition, MAb 1D3, directed to HHV-6 gH (Liu et al., 1993) , displayed a variable reactivity with HHV-7-infected CBMCs. The results are consistent with T cell clones responsive to stimulation with both HHV-6 and -7 (Yasukawa et al., 1993) . The relevance of these results bears on two issues concerning HHV-6 and -7 infections in the human population. The first issue concerns the significance of serum antibodies reacting with HHV-6-or -7-infected cells as an index of prior infection with the respective virus. A pivotal study on a limited number of sera suggested that infection with HHV-6 and -7 are acquired independently (Wyatt et al., 1991) . It should be noted that in one case seroconversion to HHV-6 and -7 occurred simultaneously (Wyatt et al., 1991) . In a subsequent survey on a higher number of samples, HHV-7 seropositivity was found in the same age groups as HHV-6 seropositivity and the potential of cross-reactive antibodies was not taken into consideration (Clark et al., 1993) . The second issue concerns the possibility that prior infection with one of the two viruses (e.g. HHV-6), and the consequent immune response, alters the pattern of the subsequent infection with the other virus (e.g. HHV-7). The availability of MAbs that display no cross-reactivity will be instrumental in the development of specific diagnostic reagents able to address these issues. They will also make it possible to verify whether, during the course of herpesvirus isolation from peripheral blood lymphocytes, HHV-7 is indeed the first virus which reactivates, and if this leads in turn to HHV-6 reactivation and outgrowth in the culture .
